re: Ann: Shareholder Newsletter - March Quart... It might be good time to sell.. It would be sad to see the share price end of week to 28-29 cents.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%